Skip to main content
Clinical Trials/CTRI/2023/04/051885
CTRI/2023/04/051885
Not yet recruiting
未知

Development of compact device using multispectral Terahertz and Fluorescence Technology for in-situ real time cancer margin detection

Dr Jyotirmayee Dash0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Jyotirmayee Dash
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Jyotirmayee Dash

Eligibility Criteria

Inclusion Criteria

  • For Inclusion, an individual must meet all of the following criteria.
  • Inability to meet all inclusion criteria for a cohort will lead to exclusion.
  • 1\. Adult males and females, aged 18 years and above
  • 2\. Provision of Informed Consent
  • 3\. Willing and able to participate in the study and provide tissue samples as per availability and feasibility.
  • 4\. No co\-morbidities which could impair study participation or sample collection,
  • 5\. Female participants: neither pregnant, nor lactating
  • 6\. For Study A (Known Cancer Cases)
  • (6a). Diagnosed with any malignancy as per current appropriate Standard of Care approach.
  • (6b). Therapy Naïve as well as received prior anticancer treatments.

Exclusion Criteria

  • For Exclusion, an individual may meet any of the following criteria.
  • Meeting even one exclusion criteria will lead to exclusion.
  • 1\. Age less than 18 years,
  • 2\. Inability to provide Informed Consent,
  • 3\. Failure to meet general or study\-specific Inclusion Criteria
  • 4\. Pregant and lactating female participants.

Outcomes

Primary Outcomes

Not specified

Similar Trials